Global Profit Technologies, Inc./ US37949N1054 /
9/18/2023 3:30:01 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0003USD | - | 6,928 Turnover: 2.0784 |
-Bid Size: - | -Ask Size: - | 0.0003 | 0.0003 |
GlobeNewswire
11/14/2023
Immatics Announces Third Quarter 2023 Financial Results and Business Update
GlobeNewswire
9/11/2023
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology...
GlobeNewswire
3/16/2022
Biogen Announces Peer-Reviewed Publication of ADUHELM® Phase 3 EMERGE and ENGAGE Data in The Journal...
GlobeNewswire
9/21/2021
OSE Immunotherapeutics Announces H1 2021 Results and Provides a Corporate Update
GlobeNewswire
3/26/2021
OSE Immunotherapeutics Reports 2020 Financial Results and Provides Business Update
GlobeNewswire
3/26/2020
OSE Immunotherapeutics Reports 2019 Financial Results and Provides Business Update Expectations for ...
GlobeNewswire
9/5/2019
OSE Immunotherapeutics Reports First Half 2019 Results and Provides a Corporate Update
GlobeNewswire
7/30/2019
Global Profit Technologies, Inc. Announces Issuance of its “GCU” Trademark by USPTO
GlobeNewswire
7/8/2019
Global Profit Technologies, Inc. Announces Release of Global Currency Unit (“GCU”)
GlobeNewswire
7/3/2019
Global Profit Technologies, Inc. Announces Release of Global Currency Unit (“GCU”)
GlobeNewswire
6/18/2019
Wildflower Featured in CannabisNewsWire Publication Highlighting Legal Cannabis as a Global Profit P...
GlobeNewswire
4/30/2019
AB Science reports today its annual financials as of 31 December 2018 and provides an update on its ...
GlobeNewswire
9/6/2018
OSE Immunotherapeutics Reports First-Half 2018 Results and Provides a Corporate Update
GlobeNewswire
4/30/2018
AB Science reports today its annual financials as of 31 December 2017 and provides an update on its ...
GlobeNewswire
4/30/2018
AB Science reports today its annual financials as of 31 December 2017 and provides an update on its ...
GlobeNewswire
3/28/2018
OSE Immunotherapeutics: 2017 Annual Results and Clinical Advances of its Proprietary and Partnered P...
GlobeNewswire
5/1/2017
AB Science reports today its annual financials as of 31 December 2016 and provides an update on its ...